Filing Details

Accession Number:
0001654954-19-006225
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-05-17 09:24:16
Reporting Period:
2019-05-15
Accepted Time:
2019-05-17 09:24:16
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1410098 Cormedix Inc. CRMD Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1489798 Janet Dillione C/o Cormedix Inc.
400 Connell Drive, Suite 5000
Berkeley Heights NJ 07922
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-05-15 11,144 $6.74 47,326 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Phantom Stock Acquisiton 2019-05-15 1,126 $0.00 226 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
226 No 4 A Direct
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock Phantom Stock $0.00 843 843 Direct
Common Stock Stock Option (Right to Buy Common Stock) $8.30 2029-01-10 15,000 15,000 Direct
Common Stock Phantom Stock $0.00 1,328 1,328 Direct
Common Stock Phantom Stock $0.00 2,728 2,728 Direct
Common Stock Phantom Stock $0.00 7,500 7,500 Direct
Common Stock Stock Option (Right to Buy Common Stock) $2.85 2028-02-16 8,000 8,000 Direct
Common Stock Phantom Stock $0.00 2,679 2,769 Direct
Common Stock Phantom Stock $0.00 3,125 3,125 Direct
Common Stock Phantom Stock $0.00 4,167 4,167 Direct
Common Stock Stock Option (Right to Buy Common Stock) $11.20 2027-02-21 8,000 8,000 Direct
Common Stock Phantom Stock $0.00 695 695 Direct
Common Stock Phantom Stock $0.00 829 829 Direct
Common Stock Stock Option (Right to Buy Common Stock) $15.15 2025-08-11 10,000 10,000 Direct
Common Stock Phantom Stock $0.00 283 283 Direct
Common Stock Stock Option (Right to Buy Common Stock) $15.15 2026-02-21 19,000 19,000 Direct
Common Stock Phantom Stock $0.00 767 767 Direct
Common Stock Phantom Stock $0.00 554 554 Direct
Common Stock Phantom Stock $0.00 867 867 Direct
Common Stock Phantom Stock $0.00 3,062 3,062 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
843 843 Direct
2029-01-10 15,000 15,000 Direct
1,328 1,328 Direct
2,728 2,728 Direct
7,500 7,500 Direct
2028-02-16 8,000 8,000 Direct
2,679 2,769 Direct
3,125 3,125 Direct
4,167 4,167 Direct
2027-02-21 8,000 8,000 Direct
695 695 Direct
829 829 Direct
2025-08-11 10,000 10,000 Direct
283 283 Direct
2026-02-21 19,000 19,000 Direct
767 767 Direct
554 554 Direct
867 867 Direct
3,062 3,062 Direct
Footnotes
  1. Represents the weighted average purchase price of the shares purchased from a low of $6.72 to a high of $6.74 per share.
  2. Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock on the tenth business day of January of the year following the reporting person's termination of service as a director.
  3. These options were granted on 01/10/2019. The options vest monthly with 100% vesting on the one year anniversary of the date of grant, subject to continued service on the board.
  4. These options were granted on 2/16/2018. The options vest in full on the first anniversary of the date of grant, subject to continued service on the board.
  5. These options were granted on 2/21/2017. The options vest in full on the first anniversary of the date of grant, subject to continued service on the board.
  6. These options were granted on 8/12/2015. The options vest as follows: 1/3 on 8/12/2015, 1/3 on 8/12/2016, and 1/3 on 8/12/2017.
  7. These options were granted on 2/21/2016. These options vest in full on the first anniversary of the date of grant, subject to continued service on the board.
  8. The issuer effected a 1-for-5 reverse stock split on March 26, 2019. All share and per share amounts shown in this Form 4 have been adjusted to reflect the reverse stock split.